Search | TVST | ARVO Journals

Showing 1 – 20 of 110

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Perspective July 2018

Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps

PDF

Jacque L. Duncan; Eric A. Pierce; Amy M. Laster; Stephen P. Daiger; David G. Birch; John D. Ash; Alessandro Iannaccone; John G. Flannery; José A. Sahel; Donald J. Zack; Marco A. Zarbin; and the Foundation Fighting Blindness Scientific Advisory Board
TAGS: mutation, genetics, genes, animal model, retinal degeneration, comprehension
Trans. Vis. Sci. Tech.. 2018; 7(4):6. doi: 10.1167/tvst.7.4.6

ARVO Annual Meeting Abstract July 2018

Natural History of Progression of Choroideremia (NIGHT) Study: Cross-Sectional Analysis of Baseline Characteristics

Byron L Lam; M Dominik Fischer; Mark E Pennesi; Eeva-Marja Kaarina Sankila; Frank G. Holz; Robert E MacLaren; David G Birch; Ian M MacDonald; Carel C B Hoyng; Graeme Black; Neil M Bressler; Stephen H. Tsang; Kimberly E Stepien; Michael S Ip; Vedran Pavlovic; Aniz Girach

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3899. doi:

ARVO Annual Meeting Abstract July 2018

Test-retest variability on the Medmont dark-adapted chromatic (DAC) perimeter in controls and patients with inherited retinal disease (IRD)

Lea D Bennett; Georgie Metz; Martin Klein; David G Birch

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4046. doi:

ARVO Annual Meeting Abstract July 2018

Progression of Stargardt disease as measured by spectral-domain optical coherence tomography (SD-OCT) in the ProgStar Study

Rupert Wolfgang Strauss; Xiangrong Kong; Beatriz E Munoz; Sheila K West; Michael S Ip; Alexander Ho; Anamika Jha; Paul S Bernstein; David G Birch; Artur V Cideciyan; Michel Michaelides; José-Alain Sahel; Janet S Sunness; Elias I Traboulsi; Eberhart Zrenner; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1568. doi:

ARVO Annual Meeting Abstract July 2018

The Natural History of the Progression of Choroideremia (NIGHT) Study: Longitudinal Changes in Visual Acuity over 12 Months

Mark E Pennesi; Byron L Lam; M Dominik Fischer; Eeva-Marja Kaarina Sankila; Frank G. Holz; Robert E MacLaren; David G Birch; Ian M MacDonald; Graeme Black; Carel C B Hoyng; Neil M Bressler; Stephen H. Tsang; Kimberly E Stepien; Michael S Ip; Vedran Pavlovic; Aniz Girach

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3898. doi:

ARVO Annual Meeting Abstract July 2018

Spatial distribution of preserved autofluorescence in patients with choroideremia

Amir H Hariri; Aniz Girach; Michael S Ip; Byron L Lam; M Dominik Fischer; Eeva-Marja Kaarina Sankila; Mark E Pennesi; Frank G. Holz; David G Birch; Robert E MacLaren; Ian M MacDonald; Carel C B Hoyng; Graeme Black; Neil M Bressler; Stephen H. Tsang; Srinivas R. Sadda

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4991. doi:

ARVO Annual Meeting Abstract July 2018

Relationships among Spectral Domain Optical Coherence Tomography (SD-OCT) Parameters and Semi-automated Kinetic Perimetry (SKP) Parameters in Subjects with Autosomal Dominant Retinitis Pigmentosa (adRP)

Kirsten G Locke; Donald C Hood; David G Birch

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):28. doi:

ARVO Annual Meeting Abstract July 2018

Static and dynamic assessment of fixation stability in Stargardt disease

Etienne M Schonbach; Artur V Cideciyan; Mohamed A Ibrahim; Rupert Wolfgang Strauss; David G Birch; Janet S Sunness; Srinivas R. Sadda; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):788. doi:

ARVO Annual Meeting Abstract July 2018

Genetic Testing Adds Research and Clinical Value to a Retinal Degeneration Registry

Kari E Branham; Joan Fisher; Karmen Trzupek; David G Birch; Jacque L Duncan; Stephen P Daiger; Brian C Mansfield

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4472. doi:

ARVO Annual Meeting Abstract July 2018

Microperimetry fixation characteristics in an Amish Population with Age-Related Macular Degeneration

Kristina Espino; Swetha Velaga; Muneeswar Gupta Nittala; Amir H Hariri; David G Birch; Dwight Stambolian; Michael S Ip; Srinivas R. Sadda

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2426. doi:

ARVO Annual Meeting Abstract July 2018

Full-Field Stimulus Thresholds (FSTs) in Subjects with Inherited Retinal Degenerations (IRDs) – a 10 Years Review

Martin Klein; Paulina Mejia; Daniel Galles; David G Birch

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):54. doi:

Special Issue September 2017

Metrics and Acquisition Modes for Fixation Stability as a Visual Function Biomarker

PDF

Etienne M. Schönbach; Mohamed A. Ibrahim; Xiangrong Kong; Rupert W. Strauss; Beatriz Muñoz; David G. Birch; Janet S. Sunness; Sheila K. West; Hendrik P. N. Scholl
TAGS: biological markers, vision, visual acuity, eye, stargardt's disease
Invest. Ophthalmol. Vis. Sci.. 2017; 58(6):BIO268-BIO276. doi: 10.1167/iovs.17-21710

Articles August 2017

Dark-Adapted Chromatic Perimetry for Measuring Rod Visual Fields in Patients with Retinitis Pigmentosa

PDF

Lea D. Bennett; Martin Klein; Kirsten G. Locke; Kelly Kiser; David G. Birch
TAGS: perimetry, retinitis pigmentosa, rod photoreceptors, visual fields
Trans. Vis. Sci. Tech.. 2017; 6(4):15. doi: 10.1167/tvst.6.4.15

ARVO Annual Meeting Abstract June 2017

Progression of Atrophic Lesions Determined by Fundus Autofluorescence: The Natural History of the Progression of Atrophy secondary to Stargardt Disease (ProgStar) Study

Rupert Wolfgang Strauss; Xiangrong Kong; Alex Ho; Anamika Jha; Michel Michaelides; Artur V Cideciyan; Jose Alain Sahel; David G Birch; Amir H Hariri; Srinivas R Sadda; Sheila West; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2013. doi:

ARVO Annual Meeting Abstract June 2017

Improvement in baseline amplitude of the scotopic b-wave after release of vitreomacular traction (VMT): Further substudy analysis from the OASIS trial (1)

Joseph I Markoff; David G Birch; Petra Kozma; Robert Sergott

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3704. doi:

ARVO Annual Meeting Abstract June 2017

Natural History and Effect of Carbonic Anhydrase Inhibitor Use in X-Linked Retinoschisis

Maria A Parker; David G Birch; Thiran Jayasundera; Laura R Erker; Rabia Gurses-Ozden; Kathleen Beasley; Jeffrey D Chulay; Mark E Pennesi

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1490. doi:

ARVO Annual Meeting Abstract June 2017

Month 18 changes in microperimetric mean sensitivity, fixation location, and fixation stability in Stargardt disease: The ProgStar Study

Etienne Schonbach; Xiangrong Kong; Mohamed A Ibrahim; Rupert Wolfgang Strauss; David G Birch; Artur V Cideciyan; Muneeswar Gupta Nittala; Janet S Sunness; Eberhart Zrenner; Srinivas R Sadda; Sheila West; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4635. doi:

ARVO Annual Meeting Abstract June 2017

EZ Width Reflects Disease Severity in adRP Patients with PRPF31 Gene Mutations

Kaylie Webb-Jones; Martin Klein; Sara J Bowne; Lori S Sullivan; Stephen P Daiger; David G Birch

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3216. doi:

ARVO Annual Meeting Abstract June 2017

SAG (S-antigen visual arrestin-1) mutations cause autosomal dominant retinitis pigmentosa (adRP) without the Oguchi disease phenotype

David G Birch; Kaylie Webb-Jones; Martin Klein; Rui Chen; Lori S Sullivan; Sara J Bowne; Stephen P Daiger

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3234. doi:

ARVO Annual Meeting Abstract June 2017

Volumetric assessment of scotopic visual field sensitivity in retinitis pigmentosa

Lea D Bennett; Richard G Weleber; Travis B Smith; Martin Klein; David G Birch

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3250. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps

Natural History of Progression of Choroideremia (NIGHT) Study: Cross-Sectional Analysis of Baseline Characteristics

Test-retest variability on the Medmont dark-adapted chromatic (DAC) perimeter in controls and patients with inherited retinal disease (IRD)

Progression of Stargardt disease as measured by spectral-domain optical coherence tomography (SD-OCT) in the ProgStar Study

The Natural History of the Progression of Choroideremia (NIGHT) Study: Longitudinal Changes in Visual Acuity over 12 Months

Spatial distribution of preserved autofluorescence in patients with choroideremia

Relationships among Spectral Domain Optical Coherence Tomography (SD-OCT) Parameters and Semi-automated Kinetic Perimetry (SKP) Parameters in Subjects with Autosomal Dominant Retinitis Pigmentosa (adRP)

Static and dynamic assessment of fixation stability in Stargardt disease

Genetic Testing Adds Research and Clinical Value to a Retinal Degeneration Registry

Microperimetry fixation characteristics in an Amish Population with Age-Related Macular Degeneration

Full-Field Stimulus Thresholds (FSTs) in Subjects with Inherited Retinal Degenerations (IRDs) – a 10 Years Review

Metrics and Acquisition Modes for Fixation Stability as a Visual Function Biomarker

Dark-Adapted Chromatic Perimetry for Measuring Rod Visual Fields in Patients with Retinitis Pigmentosa

Progression of Atrophic Lesions Determined by Fundus Autofluorescence: The Natural History of the Progression of Atrophy secondary to Stargardt Disease (ProgStar) Study

Improvement in baseline amplitude of the scotopic b-wave after release of vitreomacular traction (VMT): Further substudy analysis from the OASIS trial (1)

Natural History and Effect of Carbonic Anhydrase Inhibitor Use in X-Linked Retinoschisis

Month 18 changes in microperimetric mean sensitivity, fixation location, and fixation stability in Stargardt disease: The ProgStar Study

EZ Width Reflects Disease Severity in adRP Patients with PRPF31 Gene Mutations

SAG (S-antigen visual arrestin-1) mutations cause autosomal dominant retinitis pigmentosa (adRP) without the Oguchi disease phenotype

Volumetric assessment of scotopic visual field sensitivity in retinitis pigmentosa

To View More...

You must be signed into an individual account to use this feature.